Home Newsfeeds Microsoft Says Azure Payment HSM Now Generally Available

News

Microsoft Says Azure Payment HSM Now Generally Available

https://azure.microsoft.com/en-us/blog/secure-your-digital-payment-system-in-the-cloud-with-azure-payment-hsm-now-generally-available/

byBenzinga Newsdesk

November 1, 2022

1 minute read

https://azure.microsoft.com/en-us/blog/secure-your-digital-payment-system-in-the-cloud-with-azure-payment-hsm-now-generally-available/

News
Tech

Production Halts Continue At Toyota’s Daihatsu Amid Expanding Safety Scandal: Report

By Anan Ashraf

December 20, 12:14 AM

Toyota Motor Corp’s (NYSE:TM) subsidiary Daihatsu is reportedly planning to extend production halts amidst an escalating safety test…

Reported Late Tuesday March 7, Portillo’s Inc. Announces Pricing Of Offering Of 8M Shares Of Class A Common Stock At A Price Of $21.05/Share In “Synthetic Secondary” Transaction

By Happy Mohamed

March 8, 1:35 AM

Portillo's Inc. ("Portillo's" or the "Company") (NASDAQ:PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, today announced the pricing of its previously

PTLO

Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak’s Takeover Bid Valued Up To $7.75/Share

By Vandana Singh

April 17, 12:29 PM

Vanda Pharmaceuticals rebuffs unsolicited proposals from Future Pak LLC, citing undervaluation. Offers up to $7.75 per share. Board asserts resilient business with FDA-approved products. Future Pak urged to reconsider terms for fair shareholder value.

VNDA

Citigroup Maintains Neutral on Okta, Lowers Price Target to $115

By Benzinga Newsdesk

July 22, 11:12 AM

Citigroup analyst Fatima Boolani maintains Okta (NASDAQ:OKTA) with a Neutral and lowers the price target from $130 to $115.

OKTA

Microsoft Says Azure Payment HSM Now Generally Available

Related Posts

Production Halts Continue At Toyota’s Daihatsu Amid Expanding Safety Scandal: Report

Reported Late Tuesday March 7, Portillo’s Inc. Announces Pricing Of Offering Of 8M Shares Of Class A Common Stock At A Price Of $21.05/Share In “Synthetic Secondary” Transaction

Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak’s Takeover Bid Valued Up To $7.75/Share

Citigroup Maintains Neutral on Okta, Lowers Price Target to $115